We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lectin-Based Test Estimates Glycated Hemoglobin

By LabMedica International staff writers
Posted on 29 Feb 2012
Print article
A novel method has been developed for estimating the glycated hemoglobin (HbA1c) in normal and diabetic patients using a glucose specific lectin.

The quantitative precipitin method was performed for the interaction between the glucose-specific lectin Concanavalin A (Con A) and the glucose-containing RBC-lysate for the estimation of calculated HbA1c% from a standard curve.

Scientists at the Cancer Centre Welfare Home and Research Institute, (Kolkata, West Bengal, India) selected 16 patients of both sexes with type-2 diabetes, age range 35–60 years, and four patients with newly diagnosed type-1 diabetes, age range 15–41 years . Twenty sex-matched normal healthy subjects, age range 33-65 years, were also included as controls. A precipitation test of red cell lysate and Con-A was performed and the precipitate estimated spectrophotometrically at 480 nm. For reference, plasma glucose was estimated from the diabetic and nondiabetic subjects by glucose oxidase method using phenol 4-aminophenazone and HbA1c% were measured by ion-exchange high performance liquid chromatography (HPLC) method with the Bio-Rad D-10 analyzer (BioRad; Hercules, CA, USA).

The absorbance range of the precipitate was 0.14–0.20 in normal subjects and the corresponding calculated HbA1c% along with plasma glucose levels was 4.1%-5.8% and 82-101 mg/dL, respectively. For the diabetic patients, HbA1c results were between 6.3%-12.2%, and the plasma glucose range was 120-292 mg/dL. Similar results were observed for HbA1c% (6.1%-11.9%) of the same diabetic samples measured by conventional ion-exchange HPLC. The nondiabetic and diabetic hemoglobin variant subjects consisted of HbE-β-thalassemia, β-thalassemia carrier state, HbE trait, and HbS trait, showed similar HbA1c% by the lectin-based assay when compared with standard HPLC method.

The authors concluded that the lectin-based assay may be adopted to estimate glycated hemoglobin level in differentiating between normal and diabetic patients. This assay offers a good correlation with standard HPLC method, and moreover, the method is convenient, cheap, and needs no sophisticated instruments, and therefore suitable for laboratories in poor resource settings. The study was published online on January 24, 2012, in the Journal of Clinical Laboratory Analysis.

Related Links:

Cancer Centre Welfare Home and Research Institute
BioRad



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Automated Blood Typing System
IH-500 NEXT
New
Auto-Chemistry Analyzer
CS-1200
New
Rocking Shaker
HumaRock

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.